Commentary: Stimulating new options for heart failure management
- PMID: 35967197
- PMCID: PMC9366527
- DOI: 10.1016/j.xjtc.2022.04.016
Commentary: Stimulating new options for heart failure management
Figures
Comment on
References
-
- Heidenreich P.A., Bozkurt B., Aguilar D., Allen L.A., Byun J.J., Colvin M.M., et al. Writing Committee Members 2022 AHA/ACC/HFSA guideline for the management of heart failure. J Am Coll Cardiol. 2022;145:e895–e1032. - PubMed
-
- Writing Committee. Maddox T.M., Januzzi J.L., Jr., Allen L.A., Breathett K., Butler J., Davis L.L., et al. 2021 Update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021;77:772–810. - PubMed
-
- Karlstrom P., Alehagen U., Boman K., Dahlstrom U., UPSTEP-study group Collaborators Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome. Eur J Heart Fail. 2011;13:1096–1103. - PubMed
-
- Grassi G., Quarti-Trevano F., Esler M.D. Sympathetic activation in congestive heart failure: an updated overview. Heart Fail Rev. 2021;26:173–182. - PubMed
-
- Schwartz P.J., La Rovere M.T., De Ferrari G.M., Mann D.L. Autonomic modulation for the management of patients with chronic heart failure. Circ Heart Fail. 2015;8:619–628. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
